LVM Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$15K	–	138
2022 Q1	$15K	Hold	10,000	–	–	﹤0.01%	138
2021 Q4	$24K	Hold	10,000	–	–	﹤0.01%	130
2021 Q3	$25K	Buy	+10,000	New	+$25K	﹤0.01%	126